These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 1351846)
21. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain. Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740 [TBL] [Abstract][Full Text] [Related]
22. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors. Subramaniam S; Lucki I; McGonigle P Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781 [TBL] [Abstract][Full Text] [Related]
23. Autoradiographic localization of dopamine D2 receptors in the rat brain using the new agonist [3H]N-0437. van der Weide J; Camps M; Horn AS; Palacios JM Neurosci Lett; 1987 Dec; 83(3):259-63. PubMed ID: 2964569 [TBL] [Abstract][Full Text] [Related]
24. Dopamine D2 receptors mapped in rat brain with [3H](+)PHNO. Nobrega JN; Seeman P Synapse; 1994 Jul; 17(3):167-72. PubMed ID: 7974199 [TBL] [Abstract][Full Text] [Related]
25. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol. Altar CA; Kim H; Marshall JF J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277 [TBL] [Abstract][Full Text] [Related]
26. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain. Sóvágó J; Makkai B; Gulyás B; Hall H Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196 [TBL] [Abstract][Full Text] [Related]
27. Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system. Richfield EK; Penney JB; Young AB Neuroscience; 1989; 30(3):767-77. PubMed ID: 2528080 [TBL] [Abstract][Full Text] [Related]
28. In vivo labeling of brain dopamine D2 receptors using the high-affinity specific D2 agonist [3H]CV 205-502. Closse A; Camps M; Wanner A; Palacios JM Brain Res; 1988 Feb; 440(1):123-32. PubMed ID: 2965955 [TBL] [Abstract][Full Text] [Related]
29. Visualization of dopamine D1, D2 and D3 receptor mRNAs in human and rat brain. Mengod G; Villaró MT; Landwehrmeyer GB; Martinez-Mir MI; Niznik HB; Sunahara RK; Seeman P; O'Dowd BF; Probst A; Palacios JM Neurochem Int; 1992 Mar; 20 Suppl():33S-43S. PubMed ID: 1365451 [TBL] [Abstract][Full Text] [Related]
30. Relative affinities of dopaminergic drugs at dopamine D2 and D3 receptors. Levant B; Grigoriadis DE; De Souza EB Eur J Pharmacol; 1995 May; 278(3):243-7. PubMed ID: 7589161 [TBL] [Abstract][Full Text] [Related]
31. Dopamine D3 receptor mRNA and binding sites in human brain. Landwehrmeyer B; Mengod G; Palacios JM Brain Res Mol Brain Res; 1993 Apr; 18(1-2):187-92. PubMed ID: 8097550 [TBL] [Abstract][Full Text] [Related]
32. Autoradiographic evidence for the occlusion of rat brain dopamine D3 receptors in vivo. Schotte A; Janssen PF; Gommeren W; Luyten WH; Leysen JE Eur J Pharmacol; 1992 Aug; 218(2-3):373-5. PubMed ID: 1425949 [TBL] [Abstract][Full Text] [Related]
33. In vitro affinity of piribedil for dopamine D3 receptor subtypes, an autoradiographic study. Cagnotto A; Parotti L; Mennini T Eur J Pharmacol; 1996 Oct; 313(1-2):63-7. PubMed ID: 8905329 [TBL] [Abstract][Full Text] [Related]
34. Endogenous dopamine limits the binding of antipsychotic drugs to D3 receptors in the rat brain: a quantitative autoradiographic study. Schotte A; Janssen PF; Bonaventure P; Leysen JE Histochem J; 1996 Nov; 28(11):791-9. PubMed ID: 8968731 [TBL] [Abstract][Full Text] [Related]
35. Blockade of in vivo binding of 125I-labeled 3-iodobenzamide (IBZM) to dopamine receptors by D2 antagonist and agonist. Singhaniyom W; Tsai YF; Brücke T; McLellan CA; Cohen RM; Kung HF; Chiueh CC Brain Res; 1988 Jun; 453(1-2):393-6. PubMed ID: 2969766 [TBL] [Abstract][Full Text] [Related]
36. [Quantitative autoradiographic analysis of the binding of mosapramine to dopamine D3-receptors]. Futamura T; Shimokawa T; Morio Y; Haga K; Fukuda T Nihon Yakurigaku Zasshi; 1995 Nov; 106(5):339-46. PubMed ID: 8566910 [TBL] [Abstract][Full Text] [Related]
38. Autoradiographic distribution of [3H]YM-09151-2, a high-affinity and selective antagonist ligand for the dopamine D2 receptor group, in the rat brain and spinal cord. Yokoyama C; Okamura H; Nakajima T; Taguchi J; Ibata Y J Comp Neurol; 1994 Jun; 344(1):121-36. PubMed ID: 7914895 [TBL] [Abstract][Full Text] [Related]
39. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]